Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10155029 Terminally modified RNA

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Tirtha Chakraborty0

Antonin De Fougerolles0

Noubar B. Afeyan0

Stephane Bancel0

Stephen G. Hoge0

Atanu Roy0

Date of Patent

December 18, 2018

0

Patent Application Number

154295320

Date Filed

February 10, 2017

0

Patent Citations Received

US Patent 12023371 Terminally modified RNA

0

US Patent 10849920 Methods for therapeutic administration of messenger ribonucleic acid drugs

US Patent 10925935 Terminally Modified RNA

US Patent 11590157 Methods for therapeutic administration of messenger ribonucleic acid drugs

US Patent 11707528 Mannose-based mRNA targeted delivery system and use thereof

0

US Patent 11708396 Signal-sensor polynucleotides for the alteration of cellular phenotypes

0

US Patent 11759532 mRNA targeting molecule comprising N-acetylgalactosamine binding polypeptide and preparation method therefor

US Patent 11866754 Trinucleotide mRNA cap analogs

0

Patent Primary Examiner

0

Patent abstract

The invention relates to compositions and methods for the manufacture and optimization of modified mRNA molecules via optimization of their terminal architecture.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10155029 Terminally modified RNA

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool